Peroxisome proliferator activated receptor gamma mutation responsible for partial lipodystrophy with end stage renal disease: pharmacokinetics of metreleptine during hemodialysis: Clinical case report

Authors :: Pauline Vital
Marie-Christine Vantyghem
Corinne Vigouroux
S. Galinat
A. Drutel
Camille Plas
Francoise Archambeaud
Source :: Endocrine Abstracts.
Publication Year :: 2019
Publisher :: Bioscientifica, 2019.

Subjects :: chemistry.chemical_classification
business.industry
medicine.medical_treatment
Partial Lipodystrophy
Peroxisome proliferator-activated receptor
End stage renal disease
Métréleptine
chemistry
Pharmacokinetics
Mutation (genetic algorithm)
Cancer research
Medicine
Hemodialysis
Clinical case
business

Tools